DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg

CompletedNCT01183676

Mylan Pharmaceuticals IncHealthy

Start: 2007-07-31End: 2007-07-31Updated: 2010-08-18

Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg

CompletedNCT01184391

Mylan Pharmaceuticals IncHealthy

Start: 2007-07-31End: 2007-08-31Updated: 2010-08-18